Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells

International Journal of Cancer

Volumn 128, Issue 4, 2011, Pages 805-816

  Kang, Dong Woo ^a   Park, Mi Hee ^a   Lee, Young Jun ^a   Kim, Hyung Sik ^a   Lindsley, Craig W ^b   Alex Brown, H ^b   Min, Do Sik ^a  

^a Pusan National University   (South Korea)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autoregulation; expression; growth factor; phosphatidic acid; phospholipase D1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; RAF PROTEIN; RAS PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; AUTOREGULATION; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; UPREGULATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; RAF KINASES; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 78650591499     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25402     Document Type: Article

References (47)

1. Exton JH,. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol 2002; 144: 1-94.
2. Foster DA, Xu L,. Phospholipase D in cell proliferation and cancer. Mol Cancer Res 2003; 1: 789-800.
3. Chen MC, Paez-Espinosa V, Welsh N, Eizirik DL,. Interleukin-1beta regulates phospholipase D-1 expression in rat pancreatic beta-cells. Endocrinology 2000; 141: 2822-8.
4. Nozawa S, Ohno T, Banno Y, Dohjima T, Wakahara K, Fan DG, Shimizu K,. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells. J Biol Chem 2005; 280: 27544-51.
5. Plevin R, Cook SJ, Palmer S, Wakelam MJ,. Multiple sources of sn-1,2-diacylglycerol in platelet-derived-growth-factor-stimulated Swiss 3T3 fibroblasts. Evidence for activation of phosphoinositidase C and phosphatidylcholine-specific phospholipase D. Biochem J 1991; 279: 559-65.
6. Shome K, Rizzo MA, Vasudevan C, Andresen B, Romero G,. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 2000; 141: 2200-8.
7. Uchida N, Okamura S, Nagamachi Y, Yamashita S,. Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol 1997; 123: 280-5.
8. Huang P, Frohman MA,. The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 2007; 11: 707-16.
9. Steed PM, Clark KL, Boyar WC, Lasala DJ,. Characterization of human PLD2 and the analysis of PLD isoform splice variants. FASEB J 1998; 12: 1309-17.
10. Jenkins GM, Frohman MA,. Phospholipase D: a lipid centric review. Cell Mol Life Sci 2005; 62: 2305-16.
11. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA,. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 2009; 5: 1008-17.
12. Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D,. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 2007; 9: 706-12.
13. Mor A, Campi G, Du G, Zheng Y, Foster DA, Dustin ML, Philips MR,. The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nat Cell Biol 2007; 9: 713-19.
14. Rizzo MA, Shome K, Vasudevan C, Stolz DB, Sung TC, Frohman MA, Watkins SC, Romero G,. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J Biol Chem 1999; 274: 1131-9.
15. Ferrell JE, Xiong W,. Bistability in cell signaling: how to make continuous processes discontinuous, and reversible processes irreversible. Chaos 2001; 11: 227-36.
16. Kang DW, Park MH, Lee YJ, Kim HS, Kwon TK, Park WS, Min DS,. Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NFkappaB-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells. J Biol Chem 2008; 283: 4094-104.
17. Meng XW, Heldebrant MP, Kaufmann SH,. Phorbol 12-myristate 13-acetate inhibits death receptor-mediated apoptosis in Jurkat cells by disrupting recruitment of Fas-associated polypeptide with death domain. J Biol Chem 2002; 277: 3776-83.
18. Ahn BH, Kim SY, Kim EH, Choi KS, Kwon TK, Lee YH, Chang JS, Kim MS, Jo YH, Min DS,. Transmodulation between phospholipase D and c-Src enhances cell proliferation. Mol Cell Biol 2003; 23: 3103-15.
19. Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, Ryoo ZY, Lee YH, Lee YS, Rhie DJ, Yoon SH, Hahn SJ, et al. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 2001; 22: 1641-7.
20. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R,. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem 2003; 278: 30435-40.
21. Murthy KS, Makhlouf GM,. Agonist-mediated activation of phosphatidylcholine-specific phospholupase C and D in intestinal smooth muscle. Mol Pharmacol 1995; 48: 293-304.
22. Jiang H, Luo JQ, Urano T, Frankel P, Lu Z, Foster DA, Feig LA,. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 1995; 378: 409-12.
23. Robinson MJ, Cobb MH,. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-6.
24. Nelson DE, Ihekwaba AE, Elliott M, Johnson JR, Gibney CA, Foreman BE, Nelson G, See V, Horton CA, Spiller DG, Edwards SW, McDowell HP, et al. Oscillations in NF-κB signaling control the dynamics of gene expression. Science 2004; 306: 704-8. (Pubitemid 39440922)
25. Barken D, Wang CJ, Kearns J, Cheong R, Hoffmann A, Levchenko A,. Comment on "Oscillations in NF-κB signaling control the dynamics of gene expression". Science 2005; 308: 52.
26. Kobayashi T, Kageyama R,. Dynamic advances in NF-κB signaling analysis. Sci Signal 2009; 2: pe47.
27. Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E,. Increased expression of matrix metalloproteinases MMP-2, MMP-9 and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001; 7: 2396-404.
28. Sier CF, Kubben FJ, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, van Krieken JH, Lamers CB, Verspaget HW,. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to overall survival of patients with gastric carcinomas. Br J Cancer 1996; 74: 413-17.
29. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, Frech DL, Quigley JP,. Activation of matrix metalloproteinase 9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999; 274: 13066-77.
30. Wymann MP, Schneiter R,. Lipid signaling in disease. Nat Rev Mol Cell Biol 2008; 9: 162-76.
31. Noh DY, Ahn SJ, Lee RA, Park IA, Kim JH, Suh PG, Ryu SH, Lee KH, Han JS,. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett 2000; 161: 207-14.
32. Saito M, Iwadate M, Higashimoto M, Ono K, Takebayashi Y, Takenoshita S,. Expression of phospholipase D2 in human colorectal carcinoma. Oncol Rep 2007; 18: 1329-34.
33. Yoshida M, Okamura S, Kodaki T, Mori M, Yamashita S,. Enhanced levels of oleate-dependent and Arf-dependent phospholipase D isoforms in experimental colon cancer. Oncol Res 1998; 10: 399-406.
34. Uchida N, Okamura S, Kuwano H,. Phospholipase D activity in human gastric carcinoma. Anticancer Res 1999; 19: 671-5.
35. Zhao Y, Ehara H, Akao Y, Shamoto M, Nakagawa Y, Banno Y, Deguchi T, Ohishi N, Yagi K, Nozawa Y,. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem Biophys Res Commun 2000; 278: 140-3.
36. Kim YR, Byun HS, Won M, Park KA, Kim JM, Choi BL, Lee H, Hong JH, Park J, Seok JH, Kim DW, Shong M, et al. Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC. BMC Cancer 2008; 8: 144-54.
37. Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, Feig LA, de Kier Joffe EB, Foster DA,. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene 1999; 18: 4718-25.
38. Marshall CJ,. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
39. Buchanan FG, McReynolds M, Couvillon A, Kam Y, Holla VR, DuBois RN, Exton JH,. Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc Natl Acad Sci USA 2005; 102: 1638-42.
40. Shi M, Zheng Y, Garcia A, Foster DA,. Elevated phospholipase D activity in human cancer cells with activating Ras mutations provides survival signal. Cancer Lett 2007; 258: 268-75.
41. Bhalla US, Ram PT, Iyengar R,. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 2002; 297: 1018-23.
42. Hanafusa H, Torii S, Yasunaga T, Nishida E,. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 2002; 4: 850-8.
43. Toschi A, Lee E, Xu L, Garcia A, Gadir N, Foster DA,. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid-a competition with rapamycin. Mol Cell Biol 2009; 29: 1411-20.
44. Abdelghaffar H, Vazifeh D, Labro MT,. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L -cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway. J Immunol 1997; 159: 3995-4005.
45. Zhang Y, Du G,. Phosphatidic acid signaling regulation of Ras superfamily of small guanosine triphosphatases. Biochim Biophys Acta 2009; 1791: 850-855.
46. Wang X, Devaiah SP, Zhang W, Welti R,. Signaling functions of phosphatidic acid. Prog Lipid Res 2006; 45: 250-78.
47. Brandman O, Ferrell JE, Jr, Li R, Meyer T,. Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science 2005; 310: 496-8.